Stock Research for CERS

Current Price


Latest Update: 2018-03-20 16:00:00

$ 5.6600
$ 5.6300
$ 5.6400

Featured Broker: TradeStation

Get the due diligence for another stock.


CERS Stock Chart & Research Data

The CERS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CERS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CERS Due diligence Resources & Stock Charts

The CERS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CERS Detailed Price Forecast - CNN Money CNN View CERS Detailed Summary - Google Finance
Yahoo View CERS Detailed Summary - Yahoo! Finance Zacks View CERS Stock Research & Analysis -

Stock Analysis

TradeIdeas View CERS Trends & Analysis - Trade-Ideas Barrons View CERS Major Holders - Barrons
NASDAQ View CERS Call Transcripts - NASDAQ Seeking View CERS Breaking News & Analysis - Seeking Alpha
Spotlight View CERS Annual Report - OTC Report View CERS OTC Short Report -
TradeKing View CERS Fundamentals - TradeKing Charts View CERS SEC Filings - Bar Chart
WSJ View Historical Prices for CERS - The WSJ Morningstar View Performance/Total Return for CERS - Morningstar
MarketWatch View the Analyst Estimates for CERS - MarketWatch CNBC View the Earnings History for CERS - CNBC
StockMarketWatch View the CERS Earnings - StockMarketWatch MacroAxis View CERS Buy or Sell Recommendations - MacroAxis
Bullish View the CERS Bullish Patterns - American Bulls Short Pains View CERS Short Pain Metrics -

Social Media Mentions

StockTwits View CERS Stock Mentions - StockTwits PennyStocks View CERS Stock Mentions - PennyStockTweets
Twitter View CERS Stock Mentions - Twitter Invest Hub View CERS Investment Forum News - Investor Hub
Yahoo View CERS Stock Mentions - Yahoo! Message Board Seeking Alpha View CERS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CERS - Insider Cow View Insider Transactions for CERS - Insider Cow
CNBC View CERS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CERS - OTC Markets
Yahoo View Insider Transactions for CERS - Yahoo! Finance NASDAQ View Institutional Holdings for CERS - NASDAQ

Stock Charts

FinViz View CERS Stock Insight & Charts - StockCharts View CERS Investment Charts -
BarChart View CERS Stock Overview & Charts - BarChart Trading View View CERS User Generated Charts - Trading View

Latest Financial News for CERS

Cerus (CERS) Looks Good: Stock Adds 9.5% in Session
Posted on Monday March 19, 2018

Shares of Cerus (CERS) rose 9.5% on Friday

Wired News – FDA Accepted Tyme’s IND Application to Begin Phase-II Clinical Study for SM-88 in Pancreatic Cancer
Posted on Friday March 16, 2018

Stock Monitor: Cerus Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 16, 2018 / has just released a free research report on Tyme Technologies, Inc. (NASDAQ: TYME ). If you ...

Is Cerus Corporation’s (NASDAQ:CERS) Balance Sheet A Threat To Its Future?
Posted on Wednesday March 14, 2018

Investors are always looking for growth in small-cap stocks like Cerus Corporation (NASDAQ:CERS), with a market cap of US$664.83M. However, an important fact which most ignore is: how financially healthyRead More...

Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer
Posted on Tuesday March 13, 2018

Cerus Corporation announced today that The Community Blood Center of Appleton, Wisconsin received approval by the U.S. Food and Drug Administration on their Biologics License Application requesting allowance of interstate distribution of platelets that have been pathogen-reduced with the INTERCEPT Blood System.

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.